Health authorities and governments have been alarmed by recent epidemiological data suggesting that metabolic diseases, including obesity, diabetes mellitus type II and dyslipidemia, will grow worldwide by a much greater extent than previously expected. This has been identified as a major health problem not only for industrialised societies but also in, for example, South America, India and China.
Particularly worrisome is the increasing prevalence of obesity in children together with the onset of type II diabetes in young adults. This disturbing fact leads to the forecast that today’s children may have a lower life expectancy than their parent generation. We are therefore putting great efforts on the metabolic disease field with particular focus on diabetes type II, obesity and dyslipidemia.
|
|
|
